Natural antioxidants in hybrids for the treatment of neurodegenerative diseases: a successful strategy?
In this editorial, Sandra Gunesch, Simon Schramm and Michael Decker (Julius-Maximilians-Universität Würzburg, Germany) discuss recent in vitro and in vivo studies assessing the 'antioxidant' properties of multitarget compounds containing antioxidant moieties.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.